Preferencje help
Polish version English version Język
Widoczny [Schowaj] Abstrakt
Liczba wyników

Znaleziono wyników: 8

Liczba wyników na stronie
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników

Wyniki wyszukiwania

Wyszukiwano:
w słowach kluczowych:  preparat Metrisan AN
help Sortuj według:

help Ogranicz wyniki do:
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
1

Skutecznosc preparatu Metrisan AN w leczeniu zespolu MMA u swin

100%
Gardzinski G., Wawron W.
Medycyna Weterynaryjna
|
2001
|
tom 57
|
nr 05
330-334
2

Obserwacje terenowe nad przydatnoscia Metrisanu AN w leczeniu zapalen macicy u krow

100%
Zietara J., Wawer B.
Życie Weterynaryjne
|
1996
|
tom 71
|
nr 12
416-417
3

Metrisan AN - nowy preparat do leczenia zapalen macicy

100%
Malinowski E., Zietara J., Markiewicz H., Sobolewski J., Krupecki K.
Medycyna Weterynaryjna
|
1996
|
tom 52
|
nr 10
649-652
The purpose of studies was to elaborate and estimate the usefulness of a new preparation for treatment of metritis. The Metrisan AN was made out in the National Veterinary Research Institute on the basis of the experiences of the first author. The preparation contains the neomycin, ampicyllin as free and bound form, and components intensifying phagocytosis. The investigations were carried out on the total of 406 cows with clinical symptoms of ichoroid, purulent and muco-purulent form of metritis. It was found that one intrauterine infusion of one dose of Metrisan AN causes recovery of the endometritis III and II degree. Two doses of the Metrisan AN as first treatment and one dose given intrauterine on 7th day leads to recoveries of the ichoroid or purulent puerperal metritis. The cows which became healthy as a result of treatment with Metrisan AN had good indicators of fertility: pregnancy index, conception interval, conception after first insemination, index of insemination, and culling rate. It was also found that treatment with one dose of Metrisan AN requires no withdrawal time for milk.
4

Skutecznosc preparatu domacicznego Metrisan AN

100%
Matusik Z.
Życie Weterynaryjne
|
1997
|
tom 72
|
nr 02
53-54
5

Zastosowanie preparatu domacicznego Metrisan AN w profilaktyce zespolu MMA u swin

100%
Wawron W.
Życie Weterynaryjne
|
1997
|
tom 72
|
nr 11
438-439
6

Przebieg leczenia zapalen macicy u krow preparatem Meterisan AN

100%
Kotowski K., Dobkowicz M.
Medycyna Weterynaryjna
|
1998
|
tom 54
|
nr 09
635-637
The study was carried out in 3 cowsheds of industrial cattle husbandry on 62 black-and white lowland breed cows of different ages. Group I - 12 cows, in which until 2 weeks after parturition the observed signs were recognised as metritis ichorosa. Each cow was treated by an intrauterine infusion of two doses (two 10 ml injectors) of Metrisan, and intramuscular injection of prostaglandin. A systematic antibiotic treatment was used in the cows showing a rise in internal body temperature. Group II - 20 cows, in which during 2-4 weeks after parturition endometritis of the 3rd and 2nd degree was diagnosed. Each cow was treated with one dose of examination from 24 cows of group I and II before the infusion. Group III - 30 cows, in which signs of disease were not noticed, were the control group. The efficacy of the treatment was estimated every 7 days. The treated cows were administered the preparation twice or three times until the uterus was recognised as recovered. Altogether 10 cows were qualified for insemination (83.33%) from group I and 20 cows (100%) from group II. The bacteriological examination showed the presence of non-specific microorganisms in 19 cows (79.17%). Due to infertility, 7 cows (21.88%) were culled in the group of the cows treated with Metrisan and 3 cows (10%) in the control group. The mean calving interval for the cows treated with Metrisan was 116.4 days and did not differ significantly from the duration of this parameter in the control group (106.5 days).
7

Ocena przydatnosci preparatu Metrisan AN w zapobieganiu syndromowi MMA u loch

84%
Kotowski K., Szrom A.
Medycyna Weterynaryjna
|
1998
|
tom 54
|
nr 07
489-491
The objective of the investigation was evaluating the prophylactic efficacy of Metrisan AN in herds exposed to MMA and the effects of this preparate in practical conditions. The examinations were done on 32 sows and their progeny - 311 piglets. The sows were divided into two groups: group I -16 sows received once intrauterinarily the entire Metrisan AN contents of a syringe after parturition. Group II - 16 untreated sows served as a control. Metrisan AN contains ampicillin and neomycin and components increasing phagocytic activity of granulocytes. It was found that in group I the MMA syndrome occured in 1 sow (6.25%) but in group II (control), in 3 (18.75%) sows. Prevalence of discharges from the genital organs was comparable in the two groups but they persisted a by 2-3 day shorter period in sows treated with Metrisan AN. The differences in body weight gain between both groups of piglets were statistically insignificant. Diarrhea was present in four broods (25%) of piglets from the Metrisan AN treated sows and in 6 broods (40%) from control sows. Frequency of losses was lower by 1.57% in the experimental group compared to the control group. One can conclude that Metrisan AN applied intrauterinarily after parturition positively affects the health of sows and their progeny. It can be used as a prophylactic in herds exposed to the MMA syndrome.
8

Skutecznosc preparatu Metrisan AN w profilaktyce i terapii zapalen macicy u zwierzat domowych

67%
Krzyzanowski J., Wawron W., Wrona Z., Krakowski L., Zrebiec G.
Magazyn Weterynaryjny
|
1996
|
tom 05
|
nr 6
520-524
Pierwsza strona wyników Pięć stron wyników wstecz Poprzednia strona wyników Strona / 1 Następna strona wyników Pięć stron wyników wprzód Ostatnia strona wyników
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.